Kobayashi Pharmaceutical Co Top Insiders
KBYPFDelisted Stock | USD 32.49 0.00 0.00% |
Kobayashi Pharmaceutical employs about 3.5 K people. The company is managed by 10 executives with a total tenure of roughly 44 years, averaging almost 4.0 years of service per executive, having 345.1 employees per reported executive. Examination of Kobayashi Pharmaceutical's management performance can provide insight into the company performance.
Kazumasa Kobayashi Chairman Chairman of the Board, Chairman of Subsidiary, Representative Director |
Akihiro Kobayashi President President Executive Officer, Representative Director |
Kobayashi |
Kobayashi Pharmaceutical Management Team Effectiveness
The company has return on total asset (ROA) of 0.0633 % which means that it generated a profit of $0.0633 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0968 %, meaning that it generated $0.0968 on every $100 dollars invested by stockholders. Kobayashi Pharmaceutical's management efficiency ratios could be used to measure how well Kobayashi Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.Kobayashi Pharmaceutical Workforce Comparison
Kobayashi Pharmaceutical Co is currently regarded as number one stock in number of employees category among its peers. The total workforce of Household & Personal Products industry is now estimated at about 86,154. Kobayashi Pharmaceutical holds roughly 3,451 in number of employees claiming about 4% of equities under Household & Personal Products industry.
The company has Profit Margin (PM) of 0.12 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.16 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.16. Kobayashi Pharmaceutical Notable Stakeholders
A Kobayashi Pharmaceutical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Kobayashi Pharmaceutical often face trade-offs trying to please all of them. Kobayashi Pharmaceutical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Kobayashi Pharmaceutical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kazumasa Kobayashi | Chairman of the Board, Chairman of Subsidiary, Representative Director | Profile | |
Akihiro Kobayashi | President Executive Officer, Representative Director | Profile | |
Kazuhito Miyanishi | Executive Officer, Director of International Business | Profile | |
Satoshi Yamane | Managing Director, Executive Officer, Chief Senior Director of Headquarter Group | Profile | |
Takayuki Kimura | Gen Department | Profile | |
Tetsuji Nishioka | Sr Headquarters | Profile | |
Yoshihiro Ogawa | Sr Division | Profile | |
Naoki Ayabe | GM Area | Profile | |
Fujito Ohwaki | Sr Division | Profile | |
Takuya Matsushita | Sr Division | Profile |
About Kobayashi Pharmaceutical Management Performance
The success or failure of an entity such as Kobayashi Pharmaceutical often depends on how effective the management is. Kobayashi Pharmaceutical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Kobayashi management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Kobayashi management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan. Kobayashi Pharmaceutical operates under Household Personal Products classification in the United States and is traded on OTC Exchange. It employs 3451 people.
Kobayashi Pharmaceutical Workforce Analysis
Traditionally, organizations such as Kobayashi Pharmaceutical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Kobayashi Pharmaceutical within its industry.Kobayashi Pharmaceutical Manpower Efficiency
Return on Kobayashi Pharmaceutical Manpower
Revenue Per Employee | 45M | |
Revenue Per Executive | 15.5B | |
Net Income Per Employee | 5.7M | |
Net Income Per Executive | 2B |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Kobayashi Pink Sheet
If you are still planning to invest in Kobayashi Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kobayashi Pharmaceutical's history and understand the potential risks before investing.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Global Correlations Find global opportunities by holding instruments from different markets | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |